Clopidogrel and aplastic anaemia [8]

Lancet

Volumn 357, Issue 9266, 2001, Pages 1446-1447

  Meyer, B ^a   Staudinger, T ^a   Lechner, K ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALLOPURINOL; ANTIBIOTIC AGENT; CLOPIDOGREL; CYCLOSPORIN A; FUROSEMIDE; GLIMEPIRIDE; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROCHLOROTHIAZIDE; INSULIN; LISINOPRIL; METOPROLOL; SIMVASTATIN; THROMBOPOIETIN;

AGED; ANTIBIOTIC THERAPY; APLASTIC ANEMIA; BLOOD CELL COUNT; CLINICAL FEATURE; DRUG WITHDRAWAL; FEMALE; FEVER; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; LETTER; PANCYTOPENIA; PRIORITY JOURNAL; SEPTICEMIA; VASCULAR DISEASE;

EID: 0035810549     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)04599-2     Document Type: Letter

References (3)

1. J-M Trivier J Caron M Mathieu N Cambier C Rose Fatal aplastic anaemia associated with clopidogrel Lancet 357 2001 446
2. BB Love J Biller M Gent Adverse hematological effects of ticlopidine: prevention, recognition and management Drug Safety 19 1998 89 98
3. ME Conrad Fatal aplastic anemia associated with allopurinol therapy Am J Hematol 22 1986 107 108